April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
A New Quantifiable Blood Retinal Barrier Breakdown Model In Mice
Author Affiliations & Notes
  • Romain Benard
    INSERM, U968; UPMC Univ Paris 06, UMR_S 968, Institut de la Vision; CNRS, UMR_7210 ; CHNO des Quinze-Vingts, INSERM-DHOS CIC 503, Paris, France
  • Audrey Giocanti-Auregan
    INSERM, U968; UPMC Univ Paris 06, UMR_S 968, Institut de la Vision; CNRS, UMR_7210 ; CHNO des Quinze-Vingts, INSERM-DHOS CIC 503, Paris, France
  • Brahim El-Mathari
    Fovea Pharma, Sanofi-Aventis group, Paris, France
  • Ophélie Vacca
    INSERM, U968; UPMC Univ Paris 06, UMR_S 968, Institut de la Vision; CNRS, UMR_7210 ; CHNO des Quinze-Vingts, INSERM-DHOS CIC 503, Paris, France
  • José-Alain Sahel
    INSERM, U968; UPMC Univ Paris 06, UMR_S 968, Institut de la Vision; CNRS, UMR_7210 ; CHNO des Quinze-Vingts, INSERM-DHOS CIC 503, Paris, France
    Fondation Ophtalmologique Adolphe de Rothschild, Paris, France; Institute of Ophthalmology, University College of London, UK, Paris, France
  • Alvaro Rendon
    INSERM, U968; UPMC Univ Paris 06, UMR_S 968, Institut de la Vision; CNRS, UMR_7210 ; CHNO des Quinze-Vingts, INSERM-DHOS CIC 503, Paris, France
  • Ramin Tadayoni
    Ophthalmology department, Hôpital Lariboisière, AP-HP, Univ Paris Diderot, Paris, France; INSERM, U968; CNRS, UMR_7210 ; CHNO des Quinze-Vingts, INSERM-DHOS CIC 503, Paris, France
  • Footnotes
    Commercial Relationships  Romain Benard, None; Audrey Giocanti-Auregan, None; Brahim El-Mathari, None; Ophélie Vacca, None; José-Alain Sahel, None; Alvaro Rendon, None; Ramin Tadayoni, None
  • Footnotes
    Support  Association Française contre les Myopathies (AFM); Fédération des Aveugles de france (FAF); Allergan INC
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 4518. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Romain Benard, Audrey Giocanti-Auregan, Brahim El-Mathari, Ophélie Vacca, José-Alain Sahel, Alvaro Rendon, Ramin Tadayoni; A New Quantifiable Blood Retinal Barrier Breakdown Model In Mice. Invest. Ophthalmol. Vis. Sci. 2011;52(14):4518.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Blood retinal barrier (BRB) breakdown that induces macular edema is implicated in many diseases like diabetic retinopathy, branch and central retinal vein occlusion or ocular inflammatory diseases. There are few animal models for this complication. This study was designed to develop a new simplified and improved quantifiable BRB model in mice, and to explore the kinetics of the BRB breakdown in this model.

Methods: : To induce BRB breakdown a 30-gauge needle attached to 1 ml syringe was inserted through the limbus into the lens of adult male C57BL/6 mice. The anterior portion of the lens was aspirated and the needle was removed. To quantify the BRB permeability, Evans blue was injected at a dosage of 45 mg/kg in the Corpus cavernosum penis and detected at 620 nm by spectrophotometry. BRB permeability was quantified 24, 48, 72 and 96 h after lens surgery.

Results: : This method induced a quantifiable increase of the BRB permeability. Indeed BRB permeability increased significantly: 1,8-fold higher Evans Blue leakage at 24 h (n=10 mice, P<0,01) and 48 h (n=6, P<0,05) after lens surgery, compared to controls (n=10 mice). The BRB permeability decreased at 72 and 96 h (no significant differences compare to controls).

Conclusions: : We describe here a simplified and improved method of breaking down and quantifying the BRB in mice. The advantages of this model are: (i) its relative simplicity (ii) economy and (iii) it represents a new interesting tool to investigate for example different treatments of BRB breakdown.

Keywords: edema • pump/barrier function 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×